Sylvain Choquet
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 221 publications
Erratum: High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 11, 2026
LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
Journal: British journal of haematology
Published: May 28, 2026
Hospital at Home for BCMA-Directed Bispecific Antibodies in Multiple Myeloma: A Multicenter Real-World Feasibility and Safety Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: May 07, 2026
Short ramp-up glofitamab halves mortality risk after anti-CD19 CAR T-cell therapy failure in patients with diffuse large B-cell lymphoma: final results of the LYSA BiCAR phase 2 trial with a pre-specified external control arm.
Journal: Journal of hematology & oncology
Published: April 01, 2026
A Six-year Response to Belinostat in a Highly Probable Case of Relapsed/Refractory MF/SS Initially Classified as PTCL-NOS: A Case Report.
Journal: OncoTargets and therapy
Published: March 13, 2026
Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphoma.
Journal: Haematologica
Published: March 09, 2026
Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
Journal: Bone marrow transplantation
Published: March 09, 2026
Last Updated: 09/26/2026